Key facts
- Notable investors include Mission BioCapital, Astellas Pharma, MRL Ventures Fund, Massachusetts Life Sciences Center, Thermo Fisher Scientific — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for LabCentral
- ·The full record, as it builds
Funding rounds
No funding rounds for LabCentral are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LabCentral
Provider of business incubation and acceleration services intended to help startup entrepreneurs grow their businesses. The company's services include mentorship, coaching, workspaces, organizing promotional events, fully permitted facilities, access to shared equipment, and a collaborative community, enabling entrepreneurs and scientists to advance their research and bring creativity to market efficiently.
- Sector
- Business Products and Services (B2B)
- HQ
- North Cambridge, MA, United States
- Employees
- 94
- Website
- labcentral.org/
- Ownership
- Privately Held (backing)
LabCentral doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LabCentral shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LabCentral in its N-PORT filings yet. We sweep new filings monthly.